Microorganisms (Jan 2023)

Human Adenovirus and Influenza A Virus Exacerbate SARS-CoV-2 Infection in Animal Models

  • Victor A. Svyatchenko,
  • Vladimir A. Ternovoi,
  • Roman Y. Lutkovskiy,
  • Elena V. Protopopova,
  • Andrei S. Gudymo,
  • Nataliya V. Danilchenko,
  • Ivan M. Susloparov,
  • Nataliya P. Kolosova,
  • Alexander B. Ryzhikov,
  • Oleg S. Taranov,
  • Vladimir V. Omigov,
  • Elena V. Gavrilova,
  • Alexander P. Agafonov,
  • Rinat A. Maksyutov,
  • Valery B. Loktev

DOI
https://doi.org/10.3390/microorganisms11010180
Journal volume & issue
Vol. 11, no. 1
p. 180

Abstract

Read online

In this study, we investigated the features of the infectious process by simulating co-infection with SARS-CoV-2 and human adenovirus type 5 (HAdV-5) or influenza A virus (IAV) in vitro and in vivo. The determination of infectious activity of viruses and digital PCR demonstrated that during simultaneous and sequential HAdV-5 followed by SARS-CoV-2 infection in vitro and in vivo, the HAdV-5 infection does not interfere with replication of SARS-CoV-2. The hamsters co-infected and mono-infected with SARS-CoV-2 exhibited nearly identical viral titers and viral loads of SARS-CoV-2 in the lungs. The hamsters and ferrets co-infected by SARS-CoV-2- and IAV demonstrated more pronounced clinical manifestations than mono-infected animals. Additionally, the lung histological data illustrate that HAdV-5 or IAV and SARS-CoV-2 co-infection induces more severe pathological changes in the lungs than mono-infection. The expression of several genes specific to interferon and cytokine signaling pathways in the lungs of co-infected hamsters was more upregulated compared to single infected with SARS-CoV-2 animals. Thus, co-infection with HAdV-5 or IAV and SARS-CoV-2 leads to more severe pulmonary disease in animals.

Keywords